Home » Topics » BioWorld Science

BioWorld Science
RSS

Synairgen's phase II trial begins dosing SNG-001 in home setting to treat COVID-19

May 26, 2020

Chi-Med and BeiGene to study surufatinib and fruquintinib with tislelizumab for solid tumors

May 26, 2020

Phase III trial of efgartigimod in generalized myasthenia gravis meets primary endpoint

May 26, 2020

PEG10 found behind pathogenic mechanisms of mycosis fungoides

May 26, 2020

Germline ApoE variants affect melanoma trajectory

May 26, 2020

New TYK2 inhibitors disclosed by Bristol-Myers Squibb

May 26, 2020

Merck & Co. identifies new LRRK2 inhibitors

May 26, 2020

Esteve patents voltage-dependent calcium channel subunit alpha2/delta-1 ligands

May 26, 2020

New SSAO inhibitors identified at Boehringer Ingelheim

May 26, 2020

AiCuris discovers HBV caspid assembly inhibitors

May 26, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...